Catalyst Wire Dossier Catalyst Wire Dossier

OLOPATADINE HYDROCHLORIDE

olopatadine hydrochloride · GLENMARK THERAPEUTICS INC., USA
Drug timelines are a Plus or Pro feature.

23 regulatory and trial events tracked for OLOPATADINE HYDROCHLORIDE, covering 2012-01-25 to 2025-02-28. Get the full timeline:

Most recent: FDA Approved: OLOPATADINE HYDROCHLORIDE — Original Application (GLENMARK THERAPEUTICS INC., USA)

See pricing